Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityBBRG / Bravo Brio Restaurant Group, Inc. (10567B109)
IndustryRestaurants, Dining, and Eating Places
Institutional Owners45
Institutional Shares6,011,367 - 39.30%
Common Shares Outstanding15,295,015 shares (as of 2018-04-01)
Institutional Value$ 600,312,000 USD

Institutional Stock Ownership and Shareholders()

BBRG / Bravo Brio Restaurant Group, Inc. Institutional Ownership

Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) has 45 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,011,367 shares. Largest shareholders include BlackRock Institutional Trust Company, N.A., Aristotle Capital Boston, LLC, Eagle Boston Investment Management Inc, Dimensional Fund Advisors Lp, Bandera Partners LLC, BlackRock Inc., Vanguard Group Inc, Synovus Financial Corp, Rice Hall James & Associates, Llc, and Sei Investments Co.
Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/bbrg"><img src="https://images.fintel.io/us-bbrg-so.png" alt="BBRG / Bravo Brio Restaurant Group, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 29,129 0 -100.00 73 0 -100.00
2018-01-05 13F-HR ADDISON CLARK MANAGEMENT, L.L.C. 128,945 0 -100.00 293 0 -100.00
2017-02-10 13F-HR BlackRock Group LTD 68,298 68,298 0.00 326 260 -20.25
2018-04-25 13F-HR RICE HALL JAMES & ASSOCIATES, LLC 205,932 202,379 -1.73 515 810 57.28
2018-05-15 13F-HR Paloma Partners Management Co 0 48,700 0 195
2018-05-14 13F-HR Summit Financial Strategies, Inc. 34,529 138
2018-05-07 13F-HR SYNOVUS FINANCIAL CORP 342,511 246,818 -27.94 852 983 15.38
2018-05-02 13F-HR ALGERT GLOBAL LLC 136,678 136,678 0.00 342 547 59.94
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 674,351 638,451 -5.32 3,223 2,426 -24.73
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,200 36,549 199.58 31 146 370.97
2018-05-11 13F-HR Bandera Partners LLC 489,275 1,957
2018-05-15 13F-HR DEUTSCHE BANK AG\ 0 371 0 1
2018-05-15 13F-HR Beryl Capital Management Llc 95,770 383
2018-05-15 13F-HR VANGUARD GROUP INC 326,006 335,313 2.85 815 1,342 64.66
2018-05-15 13F-HR Bank of New York Mellon Corp 43,324 46,496 7.32 108 186 72.22
2018-05-11 13F-HR Cove Street Capital, LLC 195,200 0 -100.00 488 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 0 3 0 0
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 0 91,716 0 367
2018-04-26 13F-HR SIMPLEX TRADING, LLC 0 7,900 0 31
2018-05-09 13F-HR NORTHERN TRUST CORP 55,823 53,491 -4.18 139 214 53.96
2018-07-13 13F-HR WINSLOW ASSET MANAGEMENT INC 33,380 0 -100.00 134 0 -100.00
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 83,916 83,916 0.00 209 335 60.29
2018-05-15 13F-HR Invesco Ltd. 81,502 0 -100.00 204 0 -100.00
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 199,388 0 -100.00 498 0 -100.00
2018-05-15 13F-HR UBS Group AG 3,317 2,950 -11.06 8 12 50.00
2018-05-10 13F-HR JP Morgan Chase & Co 867 0 -100.00 2 0 -100.00
2018-05-14 13F-HR WEBER ALAN W 25,000 25,000 0.00 66 100 51.52
2018-05-15 13F-HR BARCLAYS PLC 35 103 194.29 0 0
2017-02-10 13F-HR BlackRock Advisors LLC 77,477 64,596 -16.63 370 245 -33.78
2018-05-10 13F-HR Spark Investment Management LLC 33,000 23,100 -30.00 82 92 12.20
2018-05-08 13F-HR Kassirer Asset Management Corp 116,400 466
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 486,702 503,640 3.48 1,217 2,015 65.57
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 3 3 0.00 8 12 50.00
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 14,900 14,900 0.00 37 60 62.16
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 6 0 -100.00 1 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 1,509 0 -100.00 4 0 -100.00
2018-05-14 13F-HR Virtu Financial LLC 14,937 53,068 255.28 37 213 475.68
2018-05-15 13F-HR Ancora Advisors, LLC 17,600 70
2018-05-11 13F-HR MACQUARIE GROUP LTD 12,667 0 -100.00 32 0 -100.00
2018-05-15 13F-HR TUDOR INVESTMENT CORP ET AL 15,817 15,817 0.00 40 63 57.50
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 919 8,263 799.13 2 33 1,550.00
2018-04-23 13F-HR Factorial Partners, Llc 144,255 144,255 0.00 360,637 577,020 60.00
2018-05-14 13F-HR MORGAN STANLEY 64,482 50,816 -21.19 161 203 26.09
2017-08-14 13F-HR NUMERIC INVESTORS LLC 48,726 0 -100.00 249 0 -100.00
2018-05-11 13F-HR SEI INVESTMENTS CO 70,415 150,303 113.45 176 601 241.48
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 82,487 82,606 0.14 206 330 60.19
2018-05-14 13F-HR Aristotle Capital Boston, LLC 478,746 624,049 30.35 1,197 2,496 108.52
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 52,400 52,200 -0.38 131 209 59.54
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 87,920 0 -100.00 222 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 17,702 71
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 14,663 17,702 20.73 37 71 91.89
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 131,812 122,112 -7.36 330 488 47.88
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 14,000 14,000 0.00 31 35 12.90
2018-07-05 13F-HR First Financial Bank, N.A. - Trust Division 41,160 0 -100.00 165 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 756,730 486,028 -35.77 1,891 1,944 2.80
2017-02-10 13F-HR BlackRock Fund Advisors 36,189 37,607 3.92 173 143 -17.34
2018-04-20 13F-HR STRS OHIO 200,000 0 -100.00 500 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 2,462 2,257 -8.33 12 9 -25.00
2018-05-15 13F-HR WOLVERINE ASSET MANAGEMENT LLC 137,703 550
2018-05-15 13F-HR MENTA CAPITAL LLC 24,427 24,427 0.00 61 98 60.66
2018-05-09 13F-HR EAGLE BOSTON INVESTMENT MANAGEMENT INC 571,399 585,510 2.47 1,428 2,342 64.01

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Spotlight On Gambling Reset And Banking Bill

2018-05-19 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (826-0)

CUSIP: 10567B109